Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
Main Authors: | Fischbac M, Bérard E, Decramer S, Ranchin B, Bader-Meunier B, Jurado C, Saint-Marcoux F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | Pediatric Rheumatology Online Journal |
Similar Items
-
Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
by: Indaco R, et al.
Published: (2008-09-01) -
Mycophenolate versus cyclophosphamide for lupus nephritis
by: M Sahay, et al.
Published: (2018-01-01) -
Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01) -
Successful treatment of HIV‐associated lupus‐like glomerulonephritis with mycophenolic acid
by: Mark Tiong, et al.
Published: (2020-09-01) -
Off-lable uses of mycophenolate mofetil: lupus nephritis
by: B. Fernández-García, et al.
Published: (2015-07-01)